The high molecular weight and low concentration of brain glycogen render its noninvasive quantification challenging. Therefore, the precision increase of the quantification by localized 13 C MR at 9.4 to 14.1 T was investigated. Signal-tonoise ratio increased by 66%, slightly offset by a T 1 increase of 332 6 15 to 521 6 34 ms. Isotopic enrichment after longterm 13 C administration was comparable (~40%) as was the nominal linewidth of glycogen C1 (~50 Hz). Among the factors that contributed to the 66% observed increase in signal-tonoise ratio, the T 1 relaxation time impacted the effective signal-to-noise ratio by only 10% at a repetition time 5 1 s. The signal-to-noise ratio increase together with the larger spectral dispersion at 14.1 T resulted in a better defined baseline, which allowed for more accurate fitting. Quantified glycogen concentrations were 5.8 6 0.9 mM at 9.4 T and 6.0 6 0.4 mM at 14.1 T; the decreased standard deviation demonstrates the compounded effect of increased magnetization and improved baseline on the precision of glycogen quantification. Magn Reson Med 67:1523-1527,
INTRODUCTION
Glycogen (Glyc) is a branched polysaccharide chain of glucosyl units and the main form of energy storage in the brain (1) . Glycogen has much lower concentrations in the brain than in tissues such as the liver and muscles (on the order of 5 mM vs. >100 mM in the liver) (2) , which until recently caused its importance as a cerebral energy store to be largely neglected. Furthermore, besides brain energy homeostasis, brain glycogen has been linked to memory formation (3) and neurotransmitter synthesis (4) , while its turnover has also been shown to change under physiological changes such as mild sleep deprivation (5) and lithium treatment (6) . Therefore, the precise metabolic role of brain glycogen remains to be fully elucidated (1) .
To date, 13 C localized nuclear magnetic resonance (NMR) in combination with 13 C label incorporation through a substrate such as [1- 13 C] glucose (Glc) (7) is the only method to study brain glycogen metabolism noninvasively in vivo. Several 13 C NMR methods have been proposed to quantify its concentration (8) (9) (10) , but these remain challenging and time consuming, not only due to the low amount of signal per unit of time caused by the carbon nucleus and glycogen concentration but also due to its polysaccharide structure. This latter challenge expresses itself as short T 1 and T 2 relaxation times (on the order of a few hundred and 5-10 ms, respectively; Ref. 11) , caused by long correlation times. The Glyc C1 resonance is located next to those of Glc C1b and C1a (100.5, 96.6, and 92.7 ppm, respectively), which makes the three resonances straightforward to detect at the same time, but which may hamper their peak fitting.
All of the above limitations (low relative signal, broad linewidth, and short relaxation times) change with magnetic field strength; an increase in magnetic field strength might thus have a compounded beneficial effect on the complicated quantification process. Therefore, the aim of this study was to estimate the potential improvements in the quantification of the Glyc C1 resonance when the magnetic field strength B 0 was increased from 9.4 to 14.1 T.
MATERIALS AND METHODS
To quantify brain glycogen, 13 C localized NMR spectroscopy was performed using two horizontal bore animal MR scanners (Agilent Technologies, Santa Clara, CA): an actively shielded 9.4 T/31 cm magnet and a 14.1 T/26 cm magnet. Both magnets were equipped with 12-cm innerdiameter gradient sets that allowed a maximum gradient strength of 400 mT/m in 120 ms. All experimental conditions for glycogen quantification in the two MR scanners were identical, except when specified otherwise.
In both magnets, a 14-mm quadrature 1 H coil with a single three-loop 10-mm diameter 13 C coil (12) was used for transmission and reception. As the signal-to-noise ratio (SNR) of a coil is proportional to the square root of its quality (Q)-factor: SNR $ Q 0.5 (13) , the loaded Q factors of these coils were determined on a network analyzer (Agilent Technologies); loading the coil was done by placing it on top of a 50-mL tube filled with 500 mM NaCl. The Q factor was then approximated as its resonance frequency divided by the full width at half maximum of the tuned and matched resonance (i.e., f 0 /Df) detected by a sniffer loop. Noise figures for the receive chains of both scanners were also obtained with a noise diode (Micronetics, Hudson, NH).
All animal experiments were conducted according to local guidelines after obtaining approval from the local animal ethical committee. Male Sprague-Dawley rats ($220 g, n ¼ 4 at 9.4 T, n ¼ 3 at 14.1 T, Charles River Laboratories, L'Arbresle, France) were prelabeled at the Glyc C1 position as previously described (9) , such that the Glyc C1 isotopic enrichment (IE) was high ($40%) and constant. Briefly, two evenings before the experiments, rats were fasted overnight to minimize endogenous unlabeled liver Glyc stores. The following morning, 24 h before the experiments, the rats were given 10% w/ v [1-
13 C] Glc (IE ¼ 99%, Cambridge Isotope Laboratories, Andover, MA) in tap water solution ad libitum as their only source of food and water, which would allow the glycogen IE to reach an empirically established steady state of 35-45% (9) .
Before placing the animals in the magnet, they were anesthetized with isoflurane (5% for induction and 1.8-2.0% for maintenance) in a 70:30 mixture of nitrous oxide and oxygen. After intubation and initialization of assisted breathing, a femoral artery was catheterized for blood sampling and a femoral vein was catheterized for infusion of a-chloralose (Acros Organics, Geel, Belgium) and 20% w/v [1-
13
C] Glc in saline. This Glc infusion was initially set at 40% IE through mixing of 99% [1] [2] [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] [13] C] Glc with nonlabeled Glc to reflect the previously mentioned steady state Glyc IE. The infusion rate was approximately $0.2 mg Glc/h to maintain constant euglycemia. After surgery, isoflurane was turned off and replaced by a-chloralose alone (26.7 mg/kg/h). Blood samples were taken every 30 min for blood gas and glucose analysis, which were used for according adjustments of the respiration volume and frequency (pCO 2 ¼ 39 6 2 mmHg, pO 2 > 100 mmHg, pH ¼ 7.41 6 0.03, [blood Glc] ¼ 7 6 1 mM). Temperature and breathing were monitored through a rectal probe and respiration pillow, respectively. A silicon tube with circulating warm water was placed on the body of the animal to maintain constant body temperature (T ¼ 37.7 6 0.2 C) through a feedback loop. The radiofrequency coil was then carefully positioned such that it just touched the top of the rat head (i.e., <0.5 mm distance from the top of the head for the entire 13 C loop) to optimize the use of the sensitive volume of the coil. The animal was then inserted into the MR scanner.
After FASTMAP (14) shimming (resulting in a 22 and 26 Hz water linewidth at 9.4 and 14.1 T, respectively, for a large 6 Â 8 Â 10 mm 3 voxel in the brain), the IE of N-acetyl aspartate (NAA) was determined with a carbonedited 1 H STEAM sequence, which was used to calculate the IE of brain Glyc C1 as described previously (9) . In short, this sequence uses a 13 C inversion pulse in the middle STEAM period to invert the 13 C-coupled NAA C6 resonances every other acquisition through their Jcoupling, which through subtraction edits for the 13 Ccoupled resonances to determine the 13 C-NAA/[NAA] ratio. Previous studies (9) have shown that under these experimental conditions the in vivo Glyc C1 IE is $2.2 times this NAA IE under these experimental conditions. To keep the Glyc enrichment percentage constant, the IE of the Glc infusion was changed accordingly. Localized 13 C spectroscopy was performed on a 6 Â 8 Â 10 mm 3 voxel with a modified SIRENE pulse sequence (15) , which consisted of 3D outer volume suppression, 1D inversion nulling, and an added 1D Image-Selected
In vivo Spectroscopy (ISIS) module (16) . Bilevel Waltz-16 nuclear Overhauser effect (NOE) and decoupling were applied at the Glyc/Glc 1 H frequency. The SNR of this volume was determined for nine batches of 4096 acquisitions (repetition time [TR] ¼ 1 s; total time 1 h 9 min) as the peak height divided by the root mean square of the noise after applying two times zero filling and 15 Hz line broadening. To determine the differences in T 2 * between the different field strengths, the linewidth of the Glyc resonance was determined by taking the full width at half maximum in these processed spectra and subtracting the 15 Hz line broadening. The NOE factor was determined in two animals at each field strength by also acquiring a similar batch with the NOE turned off and dividing the Glyc C1 peak integral of the batch with NOE by that of the batch without NOE.
To assess the T 1 of brain and equivalent (8, 17 ) muscle glycogen, an unlocalized inversion recovery pulse sequence consisting of an 8 ms adiabatic inversion pulse and an adiabatic excitation pulse was applied (in n ¼ 2 animals at each magnetic field strength). The inversion time (TI) was varied in 11 steps from 1 ms to 7 s. The T 1 relaxation time was determined by fitting the signal intensity S with the three-parameter equation S(TI) ¼ S ss (1 À bexp(TI/T 1 )) in OriginPro (OriginLab Corp, Northampton, MA). Here S ss is the steady state signal and b is a correction factor for taking incomplete inversion into account.
The rat was then replaced with a phantom containing 5 mM [1-
13 C] Glc and 500 mM oyster Glyc (SigmaAldrich, St. Louis, MO) to calculate their absolute concentrations as described previously (9, 10) . Briefly, the three peaks of interest (Glyc C1 as well as the a and b conformation of Glc C1) were fitted through deconvolution with a gaussian curve using built-in scanner software (Agilent Technologies, Santa Clara, CA) to determine their signal intensity S. The Glyc C1 signal and the sum of the Glc C1a and C1b integrals were then used to determine the total brain Glyc and Glc concentrations, as follows:
where G is Glc or Glyc, iv stands for in vivo, ph stands for phantom, FA is the formic acid reference bulb (used to correct for differences in coil loading), and a ¼ 0.98 is a factor to compensate for differences in T 1 and NOE between rat brain and oyster glycogen (equal to 1 for Glc). The resulting Glyc time courses were subjected to a standard Fisher F-test to determine if the hypothesis that the slope was zero could be rejected (18) . This was accomplished from a linear fit of the time course and determining if a/s a > qt 0.05,7 , where a is the slope of the linear fit, s a the standard deviation of this slope, and qt 0.05,7 ¼ 1.895 the 95% confidence quantile of the Student's t-test for the used number of degrees of freedom.
RESULTS
To account for the differences in quality between the radiofrequency coils used at the different magnetic field strengths, their loaded Q factors were determined on a network analyzer. At 14.1 T, Q ¼ 67 6 3, while at 9.4 T Q ¼ 63 6 3. The ratio of these loaded Q factors, which might have an influence on the SNR ratio between the two magnetic field strengths, was therefore 1.06. The noise figures of the 9.4 and 14.1 T scanners were 1.31 and 1.23 dB, respectively, resulting in a noise amplification of 1.16 and 1.15 and thus a factor 0.99 influence on the SNR ratio. To enhance the 13 C NMR signal, the animals were prelabeled at the Glyc C1 position. The IE of Glyc C1 as determined from the IE of NAA was similar at both field strengths (39 6 5% for n ¼ 4 animals at 9.4 T and 36 6 4% for n ¼ 3 animals at 14.1 T, see Table 1 ). During the subsequent series of localized MR measurements (1 h 9 min per time point), the Glyc C1 resonance was consistently detected with high SNR of 6-14 (Fig. 1) . The linewidths of the Glyc C1 resonance after shimming were similar and consistent at both field strengths (48 6 8 Hz at 9.4 T and 53 6 9 Hz at 14.1 T). As the inverse of these linewidths divided by p, the T 2 * relaxation times, therefore, were estimated at 6.6 6 1.1 and 5.9 6 1.0 ms at 9.4 and 14.1 T, respectively. For the convenience of discussing the SNR differences found in the study, the relative SNR, rSNR ¼ SNR 14.1 T /SNR 9.4 T is introduced here; for Glyc C1, rSNR ¼ $1.7 versus $1.5 for Glc C1b (Table 1) , while the distance of the coil from the top of the rat head was the same within 0.5 mm and the same volume of interest (480 mL) was used. The Glyc C1 NOE amplification factor was 2.8 6 0.1 at both field strengths.
The increased SNR together with the increased spectral dispersion and similar linewidths thus resulted in a more defined spectral baseline at 14.1 T: the resonances, including Glyc, were narrower (in ppm) and thus a wider and relatively flatter baseline between the resonances was apparent (Fig. 1) . This allowed for more robust spectral peak fitting, which in turn allowed for a more accurate quantification through Eq. 1, as evidenced in the halving of the error of the calculated concentration of Glyc at 14.1 T compared to 9.4 T. The quantified brain Glyc time courses clearly demonstrate this improved quantification (Fig. 2) : under the same physiological and equipment conditions, the Glyc time courses of the individual animals at 9.4 T as measured with the SIRENE sequence (Fig. 2a) have a visibly higher spread than those at 14.1 T (Fig. 2b) .
The F-tests to determine the significance of the slope of the time courses at both magnetic field strengths resulted in ratios a/s a of the slope of the linear fit and its standard deviation that ranged from 0.08 to 1.04. These were all lower than the quantile qt 0.05,7 ¼ 1.895, which signified that the hypothesis that the slope was zero could not be rejected. This then meant that no significant increase or decrease of the glycogen concentration over time could be detected within the individual animals and that the individual time courses could be taken as constant over time. When all the measurements in all the animals at a magnetic field strength were then taken together, the standard deviation at 14.1 T was less than half than that at 9.4 T (Fig. 2c): [Glyc] 9.4 T ¼ 5.8 6 0.9 mM and [Glyc] 14.1 T ¼ 6.0 6 0.4 mM. Furthermore, a two-tailed Student's t-test (a ¼ 0.05) resulted in a p ¼ 0.38 probability such that the means at 9.4 and 14.1 T were equal.
To determine the Glyc C1 T 1 relaxation time, an unlocalized adiabatic inversion recovery experiment was used. Fitting the exponential recovery curves was highly consistent and accurate: R 2 ¼ 0.998 on average in n ¼ 2 animals at both field strengths (Fig. 3) . The TR and TI were chosen long enough to allow full relaxation at the longer TIs, while the adiabatic nature of the pulses allowed for an almost complete inversion of the magnetization at short TIs despite using a surface coil. The resulting T 1 s of 332 6 15 and 521 6 34 ms demonstrate Comparing Glycogen Quantification at 9.4 and 14.1 Tan increase in T 1 , resulting in a 10% decrease in rSNR when using a TR of 1 s (11).
DISCUSSION
The Glyc concentrations at both 9.4 and 14.1 T were consistent with literature (2, 9, 10) . However, at 6.0 6 0.4 mM the time course at 14.1 T had a significantly lower standard deviation than the 5.8 6 0.9 mM at 9.4 T. The factors that could contribute to the quantification process will therefore be discussed in the following paragraphs.
We have demonstrated that the prelabeling method for Glyc labeling is consistent at different magnet field strengths and results in readily quantifiable Glyc C1 resonances at both 9.4 and 14.1 T (39 6 5 and 36 6 4%, respectively), indicating a consistent labeling to the degree that was observed in previous studies. If this nonsignificant difference is taken as an influence on the observed rSNR (rSNR obs ), a correction factor 39/36 ¼ 1.08 should be added to obtain the rSNR originating purely from differences in polarization at the two field strengths (rSNR true ). Similarly, rSNR true needs to be multiplied by 1.15/1.16 ¼ 0.99 to correct for the differences in noise figures of the receive chains.
The ratio of the loaded Q factors of the coils used at 14.1 and 9.4 T was 1.06. As SNR $ Q 0.5 , the rSNR obs overestimated the rSNR true detection by a factor 1.03.
The linewidth (and thus the estimated T 2 *) of Glyc also did not change significantly with the field increase, as expected through the field-indifferent T 2 and similar shimming. The NOE amplification at both field strengths was the same within experimental error and therefore did not contribute to the rSNR.
The calculated T 1 relaxation time increased proportionally with the magnetic field strength, consistent with literature (8, 11) . However, this increase in relaxation time also implies a relative decrease in rSNR. At the TR of 1 s, the equation for saturation recovery (S ¼ S ss [1 À exp(ÀTR/T 1 ]) results in 95% of signal recovery for T 1 ¼ 330 ms, while 85% of the signal recovers when T 1 ¼ 520 ms. The increased T 1 together with the relatively short TR, therefore, mean that the rSNR obs underestimated rSNR true by a factor 1.11 due to the incomplete recovery of the longitudinal magnetization.
With the factors above taken into account, the rSNR true ¼ 1.66*1.11*1.08*0.99/1.03 ¼ 1.91, while a factor 1.5 would be expected purely from the magnetic field strength increase (19) . However, it is the rSNR obs that plays a role in the quantification, indicating that the better definition of the baseline at 14.1 T may also contribute to the 2-fold decrease in standard deviation at 14.1 3 . Unlocalized glycogen inversion recovery curves at both field strengths illustrate the difference in T 1 relaxation time. The sequence had a sufficiently long TR (of 5 s) and sufficiently adiabatic excitation to allow full relaxation and near-full inversion. a: The fits were highly accurate (R 2 ¼ 0.998 for both curves) and resulted in T 1 ¼ 332 6 15 ms at 9.4 T (solid line) and T 1 ¼ 521 6 34 ms at 14.1 T (dashed line). To better illustrate the different recovery times, completely recovered signal after a 2.0 s TI is displayed at a smaller scale. b: Residuals of the fits show a homogeneous spread, indicating that they mainly consist of noise.
[Color figure can be viewed in the online issue, which is available at wileyonlinelibrary.com.]
